How to Help Your Patients Save Money on Epidiolex: A Provider's Guide to Savings Programs

For neurologists and epileptologists managing patients with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex, cost is one of the most significant barriers to successful Epidiolex treatment. Without proactive cost management, many families cannot sustain long-term therapy — even after a successful prior authorization. This guide provides a comprehensive overview of every available savings program and strategy for helping your patients afford Epidiolex in 2026.

Understanding the Cost Landscape for Epidiolex

Epidiolex is a brand-only specialty drug with no generic equivalent. At wholesale acquisition cost (WAC), a single 100 mL bottle was priced at $1,310 in 2020; current pricing is higher. For a 20 kg child on 10 mg/kg twice daily (20 mg/kg/day), monthly medication cost can approach or exceed $2,500-$3,000 per month at retail. This makes affordability programs not optional, but essential infrastructure for most Epidiolex patients.

The good news: Jazz Pharmaceuticals has built a comprehensive support infrastructure through JazzCares that addresses most affordability scenarios — from commercially insured patients to uninsured families. Knowing how to activate these resources for your patients is a core competency for any prescriber.

Program 1: JazzCares Copay Savings Program

The JazzCares Copay Savings Program is the primary manufacturer assistance program for commercially insured patients. Key parameters:

Eligibility: Commercially insured patients. NOT eligible if covered by Medicare Part D, Medicaid, TRICARE/VA, or other government-funded programs.

Savings: Out-of-pocket cost reduced to as little as $0 per prescription. Maximum savings limits may apply.

How to activate: Enroll patients through JazzCares at 1-833-426-4243 or at epidiolex.com/savings. Your staff can enroll patients at the time of prescribing.

Best practice: Enroll every new commercially insured Epidiolex patient in the copay program at the time of first prescription, before the specialty pharmacy contacts them.

Program 2: JazzCares Patient Assistance Program (PAP)

The JazzCares PAP is the critical safety net for patients without insurance or whose insurance does not cover Epidiolex after exhausting all appeals. Key parameters:

Eligibility: Uninsured or underinsured patients meeting income and eligibility criteria

Benefit: Free Epidiolex for eligible patients

Application: Requires physician assistance to complete — call JazzCares at 1-833-426-4243 or visit jazzcares.com/hcp/epidiolex

Timing: Apply early — PAP approval may take several weeks. The Quick Start Program (below) can bridge this gap.

Program 3: JazzCares Quick Start Program

The Quick Start Program addresses the most common access gap — the 2-4 week period between prescription submission and insurance approval. Key parameters:

What it provides: Up to four 15-day free supplies (60 days total) while awaiting insurance approval

Eligibility: Commercially insured patients and government program beneficiaries (Medicare, Medicaid, VA) experiencing a coverage delay; one lifetime use per patient

Requirements: Valid, signed prescription; JazzCares enrollment; US/Puerto Rico residents only. Cash-pay patients are not eligible.

Outcome data: ~90% of patients who use the Quick Start Program obtain insurance coverage within 30 days.

Medicare Strategies for Epidiolex Patients

For Medicare patients (including pediatric patients on Medicare due to disability), the JazzCares copay program is NOT available (as it's commercial insurance only). Key Medicare strategies:

Medicare Extra Help / Low-Income Subsidy (LIS): Significantly reduces Part D cost-sharing for eligible low-income patients. Refer patients to the Social Security Administration (1-800-772-1213) or SHIP to apply.

$2,000 Part D OOP cap (2025+): Since 2025, Medicare Part D has a $2,000 annual out-of-pocket maximum. Once reached, Epidiolex is covered 100% for the rest of the year. For many higher-dose patients, this cap may be reached relatively early in the year.

Medicare Prescription Payment Plan: As of 2025, Medicare patients can spread their OOP costs over the year in monthly payments, reducing the burden of high upfront specialty costs.

Medicaid Strategies

Medicaid coverage for Epidiolex varies significantly by state. Key strategies for Medicaid patients:

Submit thorough PA documentation including diagnosis confirmation, seizure history, and documented prior treatment failures

If denied, file a formal appeal with peer-to-peer review — often the most effective path for Medicaid PA denials

Contact your state Medicaid office to understand the formulary placement and step therapy requirements for Epidiolex in your state

JazzCares provides Medicaid-specific access support — call 1-833-426-4243 for state-specific guidance

Additional Resources for Patients Who Are Still Struggling

For patients who have exhausted all manufacturer programs and insurance options, direct them to these additional resources:

Dravet Syndrome Foundation (dravetfoundation.org) — may have emergency medication assistance

LGS Foundation (lgsfoundation.org) — family resource navigation

Tuberous Sclerosis Alliance (tsalliance.org) — TSC-specific support resources

Epilepsy Foundation (epilepsy.com) — medication assistance and resource navigation programs

Practice-Level Recommendations

Based on the above, here are practice-level recommendations for prescribers:

Train your office staff on JazzCares enrollment — it should be a standard workflow step at the time of every new Epidiolex prescription

Identify patient insurance type before prescribing — commercially insured patients have access to the copay program; government-funded patients need alternative pathways

Submit PA documentation proactively and comprehensively — the more thorough your PA submission, the fewer delays and appeals

Set a standard follow-up touchpoint at 30 days post-prescription to confirm the patient has received and is taking Epidiolex — early identification of access failures prevents prolonged treatment gaps

For additional support helping patients locate Epidiolex, visit medfinder for providers or read our provider's guide to helping patients find Epidiolex in stock.